Table 2.
Structural models considered for fluconazole pharmacokinetics
| Model | Description | Exposure | Models | Parameter values |
|---|---|---|---|---|
| M1 | One-compartment model with linear input and disposition, high CL | Low (AUC 40%↓) | ![]() |
CL = 1.32 l h−1F = 0.8 BSVF = 32% |
| M2 | One-compartment model with linear input and disposition, low CL | High (AUC 40%↑) | ![]() |
CL = 0.67 l h−1F = 0.8 BSVF = 32% |
| M3 | One-compartment model with nonlinear input and linear disposition, high Fmin | Low (AUC 40%↓) Dose = 400 mg | ![]() |
CL = 0.94 l h−1Fmin = 0.8 × FabsKmn = 470 BSVF = 32% |
| M4 | One-compartment model with nonlinear input and linear disposition, low Fmin | Low (AUC 30%↓) Dose = 400 mg | ![]() |
CL = 0.94 l h−1Fmin = 0.6 × FabsKmn = 470 BSVF = 32% |
| M5 | One-compartment model with linear input and nonlinear disposition | Low (AUC 40%↓) | ![]() |
Fmaxreabs = 0.8 Kml = 0.8 CL_int = 7.2 F = 0.8 BSVFmaxreabs = 22% BSVF = 32% BSVCL_int = 32% |
↓, reduced; ↑, increased; AUC, area under the curve; Fmin, the minimum reabsorbed fraction; Fabs, fraction absorbed; Kmn, the dose at half Fmin in the nonlinear input and linear disposition models (M3, M4); Km1, drug concentration in central compartment at half CLrmax in the linear input and nonlinear disposition model (M5); CL_reabs, reabsorbed clearance; CLrmax, the maximum reabsorbed clearance; [central cpt], the drug concentration in the central compartment. The column ‘Parameter values’ shows the values of the parameters that were perturbed from the values given in Table 1.




